Two of the six JAK2+ patients shared the MPN driver mutation between HSPCs and CECs and they were showed also the highest number of shared mutations: ABL1, IDH1 and TET2 in one case, and in ASXL1 and KMT2A in the other case. This evidence concerns the gene ABL1 and myeloproliferative neoplasm.